FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000799034> ?p ?o ?g. }

• W2000799034 endingPage "1404" @default.
• W2000799034 startingPage "1393" @default.
• W2000799034 abstract "Background & AimsCancer stem cells (CSCs) can contribute to hepatocellular carcinoma (HCC) progression and recurrence after therapy. The presence of tumor-associated macrophages (TAMs) in patients with HCC is associated with poor outcomes. It is not clear whether TAMs interact with CSCs during HCC development. We investigated whether TAMs affect the activities of CSCs in the microenvironment of human HCCs.MethodsHCCs were collected from 17 patients during surgical resection and single-cell suspensions were analyzed by flow cytometry. CD14+ TAMs were isolated from the HCC cell suspensions and placed into co-culture with HepG2 or Hep3B cells, and CSC functions were measured. The interleukin 6 (IL6) receptor was blocked with a monoclonal antibody (tocilizumab), and signal transducer and activator of transcription 3 was knocked down with small hairpin RNAs in HepG2 cells. Xenograft tumors were grown in NOD-SCID/Il2Rgnull mice from human primary HCC cells or HepG2 cells.ResultsCD44+ cells from human HCCs and cell lines formed more spheres in culture and more xenograft tumors in mice than CD44- cells, indicating that CD44+ cells are CSCs. Incubation of the CD44+ cells with TAMs promoted expansion of CD44+ cells, and increased their sphere formation in culture and formation of xenograft tumors in mice. In human HCC samples, the numbers of TAMs correlated with the numbers of CD44+ cells. Of all cytokines expressed by TAMs, IL6 was increased at the highest level in human HCC co-cultures, compared with TAMs not undergoing co-culture. IL6 was detected in the microenvironment of HCC samples and induced expansion of CD44+ cells in culture. Levels of IL6 correlated with stages of human HCCs and detection of CSC markers. Incubation of HCC cell lines with tocilizumab or knockdown of signal transducer and activator of transcription 3 in HCC cells reduced the ability of TAMs to promote sphere formation by CD44+ cells in culture and growth of xenograft tumors in mice.ConclusionsCD44+ cells isolated from human HCC tissues and cell lines have CSC activities in vitro and form a larger number of xenograft tumors in mice than CD44- cells. TAMs produce IL6, which promotes expansion of these CSCs and tumorigenesis. Levels of IL6 in human HCC samples correlate with tumor stage and markers of CSCs. Blockade of IL6 signaling with tocilizumab, a drug approved by the Food and Drug Administration for treatment of rheumatoid arthritis, inhibits TAM-stimulated activity of CD44+ cells. This drug might be used to treat patients with HCC. Cancer stem cells (CSCs) can contribute to hepatocellular carcinoma (HCC) progression and recurrence after therapy. The presence of tumor-associated macrophages (TAMs) in patients with HCC is associated with poor outcomes. It is not clear whether TAMs interact with CSCs during HCC development. We investigated whether TAMs affect the activities of CSCs in the microenvironment of human HCCs. HCCs were collected from 17 patients during surgical resection and single-cell suspensions were analyzed by flow cytometry. CD14+ TAMs were isolated from the HCC cell suspensions and placed into co-culture with HepG2 or Hep3B cells, and CSC functions were measured. The interleukin 6 (IL6) receptor was blocked with a monoclonal antibody (tocilizumab), and signal transducer and activator of transcription 3 was knocked down with small hairpin RNAs in HepG2 cells. Xenograft tumors were grown in NOD-SCID/Il2Rgnull mice from human primary HCC cells or HepG2 cells. CD44+ cells from human HCCs and cell lines formed more spheres in culture and more xenograft tumors in mice than CD44- cells, indicating that CD44+ cells are CSCs. Incubation of the CD44+ cells with TAMs promoted expansion of CD44+ cells, and increased their sphere formation in culture and formation of xenograft tumors in mice. In human HCC samples, the numbers of TAMs correlated with the numbers of CD44+ cells. Of all cytokines expressed by TAMs, IL6 was increased at the highest level in human HCC co-cultures, compared with TAMs not undergoing co-culture. IL6 was detected in the microenvironment of HCC samples and induced expansion of CD44+ cells in culture. Levels of IL6 correlated with stages of human HCCs and detection of CSC markers. Incubation of HCC cell lines with tocilizumab or knockdown of signal transducer and activator of transcription 3 in HCC cells reduced the ability of TAMs to promote sphere formation by CD44+ cells in culture and growth of xenograft tumors in mice. CD44+ cells isolated from human HCC tissues and cell lines have CSC activities in vitro and form a larger number of xenograft tumors in mice than CD44- cells. TAMs produce IL6, which promotes expansion of these CSCs and tumorigenesis. Levels of IL6 in human HCC samples correlate with tumor stage and markers of CSCs. Blockade of IL6 signaling with tocilizumab, a drug approved by the Food and Drug Administration for treatment of rheumatoid arthritis, inhibits TAM-stimulated activity of CD44+ cells. This drug might be used to treat patients with HCC." @default.
• W2000799034 created "2016-06-24" @default.
• W2000799034 creator A5005093063 @default.
• W2000799034 creator A5018902521 @default.
• W2000799034 creator A5027923944 @default.
• W2000799034 creator A5030459924 @default.
• W2000799034 creator A5033912431 @default.
• W2000799034 creator A5036533952 @default.
• W2000799034 creator A5042326252 @default.
• W2000799034 creator A5070580525 @default.
• W2000799034 creator A5088147590 @default.
• W2000799034 date "2014-12-01" @default.
• W2000799034 modified "2023-10-18" @default.
• W2000799034 title "Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells" @default.
• W2000799034 cites W1971837077 @default.
• W2000799034 cites W1979421565 @default.
• W2000799034 cites W1979728979 @default.
• W2000799034 cites W1980714336 @default.
• W2000799034 cites W1981799488 @default.
• W2000799034 cites W1984484036 @default.
• W2000799034 cites W1990376085 @default.
• W2000799034 cites W1993211204 @default.
• W2000799034 cites W2015831734 @default.
• W2000799034 cites W2023427658 @default.
• W2000799034 cites W2034929611 @default.
• W2000799034 cites W2036922484 @default.
• W2000799034 cites W2039845199 @default.
• W2000799034 cites W2051741566 @default.
• W2000799034 cites W2051935450 @default.
• W2000799034 cites W2052968488 @default.
• W2000799034 cites W2062165914 @default.
• W2000799034 cites W2068424305 @default.
• W2000799034 cites W2070059442 @default.
• W2000799034 cites W2080232352 @default.
• W2000799034 cites W2080998956 @default.
• W2000799034 cites W2081447858 @default.
• W2000799034 cites W2092268793 @default.
• W2000799034 cites W2105088175 @default.
• W2000799034 cites W2109624315 @default.
• W2000799034 cites W2111161262 @default.
• W2000799034 cites W2115754856 @default.
• W2000799034 cites W2125212735 @default.
• W2000799034 cites W2126214330 @default.
• W2000799034 cites W2142112207 @default.
• W2000799034 cites W2142300779 @default.
• W2000799034 cites W2147650118 @default.
• W2000799034 cites W2153086428 @default.
• W2000799034 cites W2158362968 @default.
• W2000799034 cites W2165477362 @default.
• W2000799034 cites W2169729679 @default.
• W2000799034 cites W2170816578 @default.
• W2000799034 cites W4245403358 @default.
• W2000799034 cites W4253752771 @default.
• W2000799034 doi "https://doi.org/10.1053/j.gastro.2014.08.039" @default.
• W2000799034 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4253315" @default.
• W2000799034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25181692" @default.
• W2000799034 hasPublicationYear "2014" @default.
• W2000799034 type Work @default.
• W2000799034 sameAs 2000799034 @default.
• W2000799034 citedByCount "484" @default.
• W2000799034 countsByYear W20007990342015 @default.
• W2000799034 countsByYear W20007990342016 @default.
• W2000799034 countsByYear W20007990342017 @default.
• W2000799034 countsByYear W20007990342018 @default.
• W2000799034 countsByYear W20007990342019 @default.
• W2000799034 countsByYear W20007990342020 @default.
• W2000799034 countsByYear W20007990342021 @default.
• W2000799034 countsByYear W20007990342022 @default.
• W2000799034 countsByYear W20007990342023 @default.
• W2000799034 crossrefType "journal-article" @default.
• W2000799034 hasAuthorship W2000799034A5005093063 @default.
• W2000799034 hasAuthorship W2000799034A5018902521 @default.
• W2000799034 hasAuthorship W2000799034A5027923944 @default.
• W2000799034 hasAuthorship W2000799034A5030459924 @default.
• W2000799034 hasAuthorship W2000799034A5033912431 @default.
• W2000799034 hasAuthorship W2000799034A5036533952 @default.
• W2000799034 hasAuthorship W2000799034A5042326252 @default.
• W2000799034 hasAuthorship W2000799034A5070580525 @default.
• W2000799034 hasAuthorship W2000799034A5088147590 @default.
• W2000799034 hasBestOaLocation W20007990341 @default.
• W2000799034 hasConcept C1491633281 @default.
• W2000799034 hasConcept C185592680 @default.
• W2000799034 hasConcept C203014093 @default.
• W2000799034 hasConcept C2778019345 @default.
• W2000799034 hasConcept C2778923194 @default.
• W2000799034 hasConcept C2779314089 @default.
• W2000799034 hasConcept C2780932548 @default.
• W2000799034 hasConcept C28328180 @default.
• W2000799034 hasConcept C502942594 @default.
• W2000799034 hasConcept C54355233 @default.
• W2000799034 hasConcept C553184892 @default.
• W2000799034 hasConcept C55427017 @default.
• W2000799034 hasConcept C62478195 @default.
• W2000799034 hasConcept C81885089 @default.
• W2000799034 hasConcept C86803240 @default.
• W2000799034 hasConcept C95444343 @default.
• W2000799034 hasConceptScore W2000799034C1491633281 @default.
• W2000799034 hasConceptScore W2000799034C185592680 @default.

• next